Kimberly-Clark Announces Third Quarter 2015 Results
Executive Summary
- Third quarter 2015 net sales of
$4.7 billion decreased 7 percent compared to the year-ago period, as changes in foreign currency exchange rates reduced sales 12 percent. Organic sales rose 5 percent, including a 10 percent increase in developing and emerging markets and a 7 percent improvement in personal care inNorth America . - Diluted net income per share for the third quarter was
$1.41 in 2015 and$1.50 in 2014. - Third quarter adjusted earnings per share were
$1.51 in 2015 compared to adjusted earnings per share from continuing operations of$1.50 in the prior year. Performance benefited from organic sales growth, cost savings, input cost deflation and a lower share count. Comparisons were negatively impacted by unfavorable foreign currency exchange rate effects, increased marketing, research and general spending on a local currency basis and higher other expense. Adjusted earnings per share in both years exclude certain items described later in this news release. - Full-year 2015 organic sales growth is expected to be 4 to 5 percent compared to the company's prior expectation of 3 to 5 percent. Full-year 2015 adjusted earnings per share are anticipated to be
$5.70 to$5.80 versus the company's previous guidance of$5.65 to$5.80 .
Chairman and Chief Executive Officer
Third Quarter 2015 Operating Results
Sales of
Third quarter operating profit was
The year-over-year adjusted operating profit comparison benefited from organic sales growth,
The third quarter adjusted effective tax rate, which excludes the effects of the previously mentioned items excluded from adjusted earnings per share, was 30.3 percent in 2015 and 31.8 percent in 2014. The company expects that the full-year 2015 adjusted effective tax rate will be in the lower half of its 31.5 to 33.5 percent target range.
Cash Flow and Balance Sheet
Cash provided by operations in the third quarter of 2015 was
Third quarter 2015 share repurchases were 1.4 million shares at a cost of
Third Quarter 2015 Business Segment Results
Personal Care Segment
Third quarter sales of
Sales in
Sales in developing and emerging markets decreased 11 percent, including a 25 percent negative impact from changes in currency rates. Volumes increased 8 percent, net selling prices improved 4 percent and product mix advanced 1 percent. The volume growth included gains in
Sales in developed markets outside
Consumer Tissue Segment
Third quarter sales of
Sales in
Sales in developing and emerging markets decreased 26 percent, including a 29 point negative impact from currency rates. Net selling prices and volumes each rose 1 percent.
Sales in developed markets outside
K-C Professional (KCP) Segment
Third quarter sales of
Sales in
Sales in developing and emerging markets decreased 19 percent, including a 25 point drag from currency rates. The combined impact of changes in net selling prices and product mix increased sales 4 percent and volumes improved 2 percent.
Sales in developed markets outside
Year-To-Date Results
For the first nine months of 2015, sales of
Year-to-date operating profit was
Through nine months, diluted net income per share was
Adjusted operating profit and adjusted earnings per share in 2015 exclude pension settlement charges, 2014 Organization Restructuring costs, a balance sheet remeasurement charge in
2014 Organization Restructuring
In
The restructuring is expected to be completed by the end of 2016, with total costs anticipated to be
2015 Outlook and Key Planning Assumptions
The company updated the following key planning and guidance assumptions for full-year 2015:
- Foreign currency translation is expected to reduce sales 10 to 11 percent (prior assumption 10 percent) and reduce operating profit 11 to 12 percent (prior expectation 11 percent).
- Organic sales, which exclude the impact of changes in foreign currency rates, are anticipated to grow 4 to 5 percent versus the prior assumption of 3 to 5 percent.
- Adjusted earnings per share are expected to be
$5.70 to$5.80 versus the company's previous guidance of$5.65 to$5.80 .
Non-GAAP Financial Measures
This press release and the accompanying tables include the following financial measures that have not been calculated in accordance with accounting principles generally accepted in the U.S., or GAAP, and are therefore referred to as non-GAAP financial measures:
- Adjusted earnings and earnings per share (including continuing operations)
- Adjusted gross and operating profit
- Adjusted other (income) and expense, net
- Adjusted effective tax rate
These non-GAAP financial measures exclude the following items for the relevant time periods as indicated in the accompanying non-GAAP reconciliations to the comparable GAAP financial measures:
- Pension settlement charges. In 2015, the company started to offer a lump-sum pension benefit payout option for certain plan participants. In addition,
Kimberly-Clark purchased group annuity contracts that transferred to two insurance companies the pension benefit obligations for certainKimberly-Clark retirees. As a result, the company recognized pension settlement charges in the first nine months of 2015, mostly in the second quarter. - 2014 Organization Restructuring. See previous discussion in this news release.
Turkey restructuring. In the third quarter of 2015, the company initiated actions to restructure its business inTurkey , including the closing of a manufacturing facility. The company expects to incur total after tax charges of approximately$25 million in the third and fourth quarters of 2015 for this restructuring. The company acquired the remaining 49.9 percent interest in its subsidiary inTurkey in conjunction with the acquisition of the remaining 49.9 percent interest in its subsidiary inIsrael in the first quarter of 2015.- Venezuelan balance sheet remeasurement. In the first quarter of 2015, following the Venezuelan government's elimination of the SICAD II exchange rate, the company recorded a charge for remeasuring the local currency balance sheet in
Venezuela at the new SIMADI floating exchange rate. - Regulatory dispute in the
Middle East . In the first quarter of 2014, the company recorded a non-deductible charge as a result of an adverse court ruling regarding the treatment of capital contributions in prior years to an affiliate in theMiddle East . - Western and
Central Europe strategic changes and related restructuring charges. InOctober 2012 , the company initiated strategic changes and a related restructuring in its Western and Central European businesses. The restructuring was completed at the end of 2014.
In addition, this press release includes information regarding organic sales, which exclude the impact of changes in foreign currency rates.
The company provides these non-GAAP financial measures as supplemental information to our GAAP financial measures. Management and the company's Board of Directors use adjusted earnings, adjusted earnings per share and adjusted gross and operating profit to (a) evaluate the company's historical and prospective financial performance and its performance relative to its competitors, (b) allocate resources and (c) measure the operational performance of the company's business units and their managers. Management also believes that the use of an adjusted effective tax rate provides improved insight into the tax effects of our ongoing business operations.
Additionally, the
Conference Call
A conference call to discuss this news release and other matters of interest to investors and analysts will be held at
About
Copies of
Certain matters contained in this news release concerning the outlook, anticipated financial and operating results, raw material, energy and other input costs, anticipated currency rates and exchange risks, net income from equity companies, sources and uses of cash, the effective tax rate, the anticipated costs, scope, timing and financial and other effects of the 2014 Organization Restructuring, growth initiatives, contingencies and anticipated transactions of the company constitute forward-looking statements and are based upon management's expectations and beliefs concerning future events impacting the company. There can be no assurance that these future events will occur as anticipated or that the company's results will be as estimated. Forward-looking statements speak only as of the date they were made, and we undertake no obligation to publicly update them. For a description
of certain factors, such as currency rates and exchange risks, cost savings and reductions, raw material, energy and other input costs, competition, market demand and economic and political conditions, that could cause the company's future results to differ from those expressed in any such forward-looking statements, see Item 1A of the company's Annual Report on Form 10-K for the year ended
|
CONSOLIDATED INCOME STATEMENT (Millions, except per share amounts) | ||||||||||
|
Three Months Ended |
||||||||||
|
2015 |
2014 |
Change | ||||||||
|
Net Sales |
$ |
4,718 |
$ |
5,056 |
-6.7 |
% | ||||
|
Cost of products sold |
3,036 |
3,291 |
-7.7 |
% | ||||||
|
Gross Profit |
1,682 |
1,765 |
-4.7 |
% | ||||||
|
Marketing, research and general expenses |
868 |
904 |
-4.0 |
% | ||||||
|
Other (income) and expense, net |
35 |
(16) |
N.M. |
|||||||
|
Operating Profit |
779 |
877 |
-11.2 |
% | ||||||
|
Interest income |
4 |
5 |
-20.0 |
% | ||||||
|
Interest expense |
(74) |
(72) |
+2.8 |
% | ||||||
|
Income From Continuing Operations Before Income Taxes and Equity Interests |
709 |
810 |
-12.5 |
% | ||||||
|
Provision for income taxes |
(217) |
(260) |
-16.5 |
% | ||||||
|
Income From Continuing Operations Before Equity Interests |
492 |
550 |
-10.5 |
% | ||||||
|
Share of net income of equity companies |
37 |
31 |
+19.4 |
% | ||||||
|
Income From Continuing Operations |
529 |
581 |
-9.0 |
% | ||||||
|
Income from discontinued operations, net of income taxes |
— |
1 |
N.M. |
|||||||
|
Net Income |
529 |
582 |
-9.1 |
% | ||||||
|
Net income attributable to noncontrolling interests in continuing operations |
(12) |
(20) |
-40.0 |
% | ||||||
|
Net Income Attributable to |
$ |
517 |
$ |
562 |
-8.0 |
% | ||||
|
Per Share Basis |
||||||||||
|
Net Income Attributable to |
||||||||||
|
Basic |
||||||||||
|
Continuing operations |
$ |
1.42 |
$ |
1.50 |
-5.3 |
% | ||||
|
Discontinued operations |
— |
— |
— |
|||||||
|
Rounding |
— |
0.01 |
N.M. |
|||||||
|
Net income |
$ |
1.42 |
$ |
1.51 |
-6.0 |
% | ||||
|
Diluted |
||||||||||
|
Continuing operations |
$ |
1.41 |
$ |
1.49 |
-5.4 |
% | ||||
|
Discontinued operations |
— |
— |
— |
|||||||
|
Rounding |
— |
0.01 |
N.M. |
|||||||
|
Net income |
$ |
1.41 |
$ |
1.50 |
-6.0 |
% | ||||
|
Cash Dividends Declared |
$ |
0.88 |
$ |
0.84 |
+4.8 |
% | ||||
|
Common Shares Outstanding |
|
|||||||||
|
2015 |
2014 |
|||||||||
|
Outstanding shares as of |
363.3 |
372.5 |
||||||||
|
Average diluted shares for three months ended |
366.2 |
375.9 |
||||||||
|
N.M. - Not Meaningful Unaudited |
||||||||||
|
CONSOLIDATED INCOME STATEMENT (Millions, except per share amounts) | ||||||||||
|
Nine Months Ended |
||||||||||
|
2015 |
2014 |
Change | ||||||||
|
Net Sales |
$ |
14,052 |
$ |
14,896 |
-5.7 |
% | ||||
|
Cost of products sold |
9,054 |
9,766 |
-7.3 |
% | ||||||
|
Gross Profit |
4,998 |
5,130 |
-2.6 |
% | ||||||
|
Marketing, research and general expenses |
2,586 |
2,738 |
-5.6 |
% | ||||||
|
Other (income) and expense, net |
1,429 |
29 |
N.M. |
|||||||
|
Operating Profit |
983 |
2,363 |
-58.4 |
% | ||||||
|
Interest income |
12 |
13 |
-7.7 |
% | ||||||
|
Interest expense |
(219) |
(215) |
+1.9 |
% | ||||||
|
Income From Continuing Operations Before Income Taxes and Equity Interests |
776 |
2,161 |
-64.1 |
% | ||||||
|
Provision for income taxes |
(166) |
(681) |
-75.6 |
% | ||||||
|
Income From Continuing Operations Before Equity Interests |
610 |
1,480 |
-58.8 |
% | ||||||
|
Share of net income of equity companies |
112 |
113 |
-0.9 |
% | ||||||
|
Income From Continuing Operations |
722 |
1,593 |
-54.7 |
% | ||||||
|
Income from discontinued operations, net of income taxes |
— |
65 |
N.M. |
|||||||
|
Net Income |
722 |
1,658 |
-56.5 |
% | ||||||
|
Net income attributable to noncontrolling interests in continuing operations |
(42) |
(49) |
-14.3 |
% | ||||||
|
Net Income Attributable to |
$ |
680 |
$ |
1,609 |
-57.7 |
% | ||||
|
Per Share Basis |
||||||||||
|
Net Income Attributable to |
||||||||||
|
Basic |
||||||||||
|
Continuing operations |
$ |
1.87 |
$ |
4.11 |
-54.5 |
% | ||||
|
Discontinued operations |
— |
0.17 |
N.M. |
|||||||
|
Net income |
$ |
1.87 |
$ |
4.28 |
-56.3 |
% | ||||
|
Diluted |
||||||||||
|
Continuing operations |
$ |
1.85 |
$ |
4.08 |
-54.7 |
% | ||||
|
Discontinued operations |
— |
0.17 |
N.M. |
|||||||
|
Net income |
$ |
1.85 |
$ |
4.25 |
-56.5 |
% | ||||
|
Cash Dividends Declared |
$ |
2.64 |
$ |
2.52 |
+4.8 |
% | ||||
|
Common Shares Outstanding |
|
|||||||||
|
2015 |
2014 |
|||||||||
|
Average diluted shares for nine months ended |
366.9 |
378.8 |
||||||||
|
N.M. - Not Meaningful Unaudited |
||||||||||
|
NON-GAAP RECONCILIATIONS (Millions, except per share amounts) | ||||||||||||||||||||
|
Three Months Ended | ||||||||||||||||||||
|
As Reported |
Charges for Pension Settlements |
Charges for 2014 |
Charges for Turkey Restructuring |
As Adjusted Non- | ||||||||||||||||
|
Cost of products sold |
$ |
3,036 |
$ |
— |
$ |
4 |
$ |
16 |
$ |
3,016 |
||||||||||
|
Gross profit |
1,682 |
— |
(4) |
(16) |
1,702 |
|||||||||||||||
|
Marketing, research and general expenses |
868 |
— |
7 |
1 |
860 |
|||||||||||||||
|
Other (income) and expense, net |
35 |
19 |
— |
— |
16 |
|||||||||||||||
|
Operating profit |
779 |
(19) |
(11) |
(17) |
826 |
|||||||||||||||
|
Income from continuing operations before income taxes and equity interests |
709 |
(19) |
(11) |
(17) |
756 |
|||||||||||||||
|
Provision for income taxes |
(217) |
8 |
4 |
— |
(229) |
|||||||||||||||
|
Effective tax rate |
30.6 |
% |
— |
— |
— |
30.3 |
% | |||||||||||||
|
Net income attributable to |
517 |
(11) |
(7) |
(17) |
552 |
|||||||||||||||
|
Diluted earnings per share |
1.41 |
(0.03) |
(0.02) |
(0.05) |
1.51 |
|||||||||||||||
|
Three Months Ended | ||||||||||||||||||||
|
As Reported |
Charges for |
As Adjusted Non- | ||||||||||||||||||
|
Cost of products sold |
$ |
3,291 |
$ |
1 |
$ |
3,290 |
||||||||||||||
|
Gross profit |
1,765 |
(1) |
1,766 |
|||||||||||||||||
|
Operating profit |
877 |
(1) |
878 |
|||||||||||||||||
|
Income from continuing operations before income taxes and equity interests |
810 |
(1) |
811 |
|||||||||||||||||
|
Provision for income taxes |
(260) |
(2) |
(258) |
|||||||||||||||||
|
Effective tax rate |
32.1 |
% |
— |
31.8 |
% | |||||||||||||||
|
Income from continuing operations |
581 |
(3) |
584 |
|||||||||||||||||
|
Net income attributable to noncontrolling interests in continuing operations |
(20) |
— |
(20) |
|||||||||||||||||
|
Income from continuing operations attributable to |
561 |
(3) |
564 |
|||||||||||||||||
|
Diluted earnings per share from continuing operations |
1.49 |
(0.01) |
1.50 |
|||||||||||||||||
|
Non-GAAP financial measures are not meant to be considered in isolation or as a substitute for the comparable GAAP measures, and they should be read only in conjunction with the company's consolidated financial statements prepared in accordance with GAAP. There are limitations to these non-GAAP financial measures because they are not prepared in accordance with GAAP and may not be comparable to similarly titled measures of other companies due to potential differences in methods of calculation and items being excluded. The company compensates for these limitations by using these non-GAAP financial measures as a supplement to the GAAP measures and by providing reconciliations of the non-GAAP and comparable GAAP financial measures. |
|
Unaudited |
|
NON-GAAP RECONCILIATIONS (Millions, except per share amounts) | ||||||||||||||||||||||||
|
Nine Months Ended | ||||||||||||||||||||||||
|
As Reported |
Charges for Pension Settlements |
Charges for |
Charge for |
Charges for |
As Adjusted Non-GAAP | |||||||||||||||||||
|
Cost of products sold |
$ |
9,054 |
$ |
— |
$ |
19 |
$ |
5 |
$ |
16 |
$ |
9,014 |
||||||||||||
|
Gross profit |
4,998 |
— |
(19) |
(5) |
(16) |
5,038 |
||||||||||||||||||
|
Marketing, research and general expenses |
2,586 |
— |
17 |
— |
1 |
2,568 |
||||||||||||||||||
|
Other (income) and expense, net |
1,429 |
1,350 |
— |
40 |
— |
39 |
||||||||||||||||||
|
Operating profit |
983 |
(1,350) |
(36) |
(45) |
(17) |
2,431 |
||||||||||||||||||
|
Income from continuing operations before income taxes and equity interests |
776 |
(1,350) |
(36) |
(45) |
(17) |
2,224 |
||||||||||||||||||
|
Provision for income taxes |
(166) |
520 |
16 |
— |
— |
(702) |
||||||||||||||||||
|
Effective tax rate |
21.4 |
% |
— |
— |
— |
— |
31.6 |
% | ||||||||||||||||
|
Net income attributable to |
680 |
(830) |
(20) |
(45) |
(17) |
1,592 |
||||||||||||||||||
|
Diluted earnings per share(a) |
1.85 |
(2.26) |
(0.05) |
(0.12) |
(0.05) |
4.34 |
||||||||||||||||||
|
Nine Months Ended | ||||||||||||||||||||||||
|
As Reported |
Charges for |
Charge Related to |
As Adjusted Non-GAAP | |||||||||||||||||||||
|
Cost of products sold |
$ |
9,766 |
$ |
9 |
$ |
— |
$ |
9,757 |
||||||||||||||||
|
Gross profit |
5,130 |
(9) |
— |
5,139 |
||||||||||||||||||||
|
Marketing, research and general expenses |
2,738 |
4 |
— |
2,734 |
||||||||||||||||||||
|
Other (income) and expense, net |
29 |
— |
39 |
(10) |
||||||||||||||||||||
|
Operating profit |
2,363 |
(13) |
(39) |
2,415 |
||||||||||||||||||||
|
Income from continuing operations before income taxes and equity interests |
2,161 |
(13) |
(39) |
2,213 |
||||||||||||||||||||
|
Provision for income taxes |
(681) |
1 |
— |
(682) |
||||||||||||||||||||
|
Effective tax rate |
31.5 |
% |
— |
— |
30.8 |
% | ||||||||||||||||||
|
Income from continuing operations |
1,593 |
(12) |
(39) |
1,644 |
||||||||||||||||||||
|
Net income attributable to noncontrolling interests in continuing operations |
(49) |
— |
20 |
(69) |
||||||||||||||||||||
|
Income from continuing operations attributable to |
1,544 |
(12) |
(19) |
1,575 |
||||||||||||||||||||
|
Diluted earnings per share from continuing operations |
4.08 |
(0.03) |
(0.05) |
4.16 |
||||||||||||||||||||
|
(a) "As Adjusted Non-GAAP" does not equal "As Reported" plus "Charges" as a result of rounding. |
||||||||||||||||||||||||
|
Unaudited |
||||||||||||||||||||||||
|
CONSOLIDATED BALANCE SHEET (Millions) | |||||||
|
|
| ||||||
|
ASSETS |
|||||||
|
Current Assets |
|||||||
|
Cash and cash equivalents |
$ |
643 |
$ |
789 |
|||
|
Accounts receivable, net |
2,284 |
2,223 |
|||||
|
Inventories |
1,883 |
1,892 |
|||||
|
Other current assets |
632 |
655 |
|||||
|
Total Current Assets |
5,442 |
5,559 |
|||||
|
Property, Plant and Equipment, Net |
7,066 |
7,359 |
|||||
|
Investments in Equity Companies |
279 |
257 |
|||||
|
Goodwill |
1,435 |
1,628 |
|||||
|
Other Assets |
706 |
723 |
|||||
|
TOTAL ASSETS |
$ |
14,928 |
$ |
15,526 |
|||
|
LIABILITIES AND STOCKHOLDERS' EQUITY |
|||||||
|
Current Liabilities |
|||||||
|
Debt payable within one year |
$ |
1,460 |
$ |
1,326 |
|||
|
Trade accounts payable |
2,518 |
2,616 |
|||||
|
Accrued expenses |
1,903 |
1,974 |
|||||
|
Dividends payable |
320 |
310 |
|||||
|
Total Current Liabilities |
6,201 |
6,226 |
|||||
|
Long-Term Debt |
6,125 |
5,630 |
|||||
|
Noncurrent Employee Benefits |
1,312 |
1,693 |
|||||
|
Deferred Income Taxes |
626 |
587 |
|||||
|
Other Liabilities |
316 |
319 |
|||||
|
Redeemable Preferred Securities of Subsidiaries |
72 |
72 |
|||||
|
Stockholders' Equity |
|||||||
|
|
54 |
729 |
|||||
|
Noncontrolling Interests |
222 |
270 |
|||||
|
Total Stockholders' Equity |
276 |
999 |
|||||
|
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY |
$ |
14,928 |
$ |
15,526 |
|||
|
2015 Data is Unaudited | |||||||
|
CONSOLIDATED CASH FLOW STATEMENT (Millions) | |||||||||||||||
|
Three Months Ended |
Nine Months Ended | ||||||||||||||
|
2015 |
2014 |
2015 |
2014 | ||||||||||||
|
Operating Activities |
|||||||||||||||
|
Net income |
$ |
529 |
$ |
582 |
$ |
722 |
$ |
1,658 |
|||||||
|
Depreciation and amortization |
182 |
220 |
565 |
655 |
|||||||||||
|
Asset impairments |
20 |
— |
20 |
42 |
|||||||||||
|
Stock-based compensation |
17 |
15 |
68 |
51 |
|||||||||||
|
Deferred income taxes |
(32) |
(6) |
(378) |
57 |
|||||||||||
|
Equity companies' earnings (in excess of) less than dividends paid |
(1) |
9 |
(38) |
(27) |
|||||||||||
|
(Increase) decrease in operating working capital |
101 |
152 |
(316) |
(63) |
|||||||||||
|
Postretirement benefits |
33 |
16 |
941 |
(119) |
|||||||||||
|
Charge for Venezuelan balance sheet remeasurement |
— |
— |
45 |
— |
|||||||||||
|
Other |
— |
(12) |
12 |
1 |
|||||||||||
|
Cash Provided by Operations |
849 |
976 |
1,641 |
2,255 |
|||||||||||
|
Investing Activities |
|||||||||||||||
|
Capital spending |
(271) |
(291) |
(798) |
(730) |
|||||||||||
|
Proceeds from sales of investments |
— |
3 |
— |
96 |
|||||||||||
|
Investments in time deposits |
(18) |
(10) |
(100) |
(123) |
|||||||||||
|
Maturities of time deposits |
9 |
9 |
100 |
191 |
|||||||||||
|
Other |
(17) |
45 |
(25) |
41 |
|||||||||||
|
Cash Used for Investing |
(297) |
(244) |
(823) |
(525) |
|||||||||||
|
Financing Activities |
|||||||||||||||
|
Cash dividends paid |
(321) |
(315) |
(952) |
(942) |
|||||||||||
|
Change in short-term debt |
(292) |
(126) |
(109) |
153 |
|||||||||||
|
Debt proceeds |
587 |
5 |
1,097 |
621 |
|||||||||||
|
Debt repayments |
(305) |
(3) |
(349) |
(109) |
|||||||||||
|
Proceeds from exercise of stock options |
20 |
17 |
102 |
98 |
|||||||||||
|
Acquisitions of common stock for the treasury |
(145) |
(205) |
(503) |
(1,122) |
|||||||||||
|
Shares purchased from noncontrolling interest |
— |
— |
(151) |
— |
|||||||||||
|
Other |
1 |
(15) |
6 |
(22) |
|||||||||||
|
Cash Used for Financing |
(455) |
(642) |
(859) |
(1,323) |
|||||||||||
|
Effect of Exchange Rate Changes on Cash and Cash Equivalents |
(57) |
(28) |
(105) |
(30) |
|||||||||||
|
Increase (Decrease) in Cash and Cash Equivalents |
40 |
62 |
(146) |
377 |
|||||||||||
|
Cash and Cash Equivalents - Beginning of Period |
603 |
1,369 |
789 |
1,054 |
|||||||||||
|
Cash and Cash Equivalents - End of Period |
$ |
643 |
$ |
1,431 |
$ |
643 |
$ |
1,431 |
|||||||
|
Unaudited | |||||||||||||||
|
SELECTED BUSINESS SEGMENT DATA (Millions) | ||||||||||||||||||||||
|
Three Months Ended |
Nine Months Ended |
|||||||||||||||||||||
|
2015 |
2014 |
Change |
2015 |
2014 |
Change | |||||||||||||||||
|
NET SALES |
||||||||||||||||||||||
|
Personal Care |
$ |
2,357 |
$ |
2,475 |
-4.8 |
% |
$ |
6,971 |
$ |
7,299 |
-4.5 |
% | ||||||||||
|
Consumer Tissue |
1,528 |
1,697 |
-10.0 |
% |
4,601 |
5,024 |
-8.4 |
% | ||||||||||||||
|
K-C Professional |
826 |
873 |
-5.4 |
% |
2,443 |
2,531 |
-3.5 |
% | ||||||||||||||
|
Corporate & Other |
7 |
11 |
N.M. |
37 |
42 |
N.M. |
||||||||||||||||
|
TOTAL NET SALES |
$ |
4,718 |
$ |
5,056 |
-6.7 |
% |
$ |
14,052 |
$ |
14,896 |
-5.7 |
% | ||||||||||
|
OPERATING PROFIT |
||||||||||||||||||||||
|
Personal Care |
$ |
484 |
$ |
483 |
+0.2 |
% |
$ |
1,412 |
$ |
1,393 |
+1.4 |
% | ||||||||||
|
Consumer Tissue |
260 |
285 |
-8.8 |
% |
811 |
782 |
+3.7 |
% | ||||||||||||||
|
K-C Professional |
154 |
165 |
-6.7 |
% |
433 |
453 |
-4.4 |
% | ||||||||||||||
|
Corporate & Other(a) |
(84) |
(72) |
N.M. |
(244) |
(236) |
N.M. |
||||||||||||||||
|
Other (income) and expense, net(b) |
35 |
(16) |
N.M. |
1,429 |
29 |
N.M. |
||||||||||||||||
|
TOTAL OPERATING PROFIT |
$ |
779 |
$ |
877 |
-11.2 |
% |
$ |
983 |
$ |
2,363 |
-58.4 |
% | ||||||||||
|
(a) |
Corporate & Other includes charges related to the 2014 Organization Restructuring of |
|
(b) |
Other (income) and expense, net includes charges for pension settlements of |
|
N.M. - Not Meaningful Unaudited | |
|
SELECTED BUSINESS SEGMENT DATA | |||||||||||||
|
PERCENTAGE CHANGE IN NET SALES VERSUS PRIOR YEAR | |||||||||||||
|
Three Months Ended | |||||||||||||
|
Total |
Volume |
Net Price |
Mix/ Other(a) |
Currency | |||||||||
|
Personal Care |
(4.8) |
7 |
— |
1 |
(13) | ||||||||
|
Consumer Tissue |
(10.0) |
2 |
(1) |
— |
(11) | ||||||||
|
K-C Professional |
(5.4) |
2 |
— |
3 |
(10) | ||||||||
|
TOTAL CONSOLIDATED |
(6.7) |
5 |
— |
— |
(12) | ||||||||
|
Nine Months Ended | |||||||||||||
|
Total |
Volume |
Net Price |
Mix/ Other(a) |
Currency | |||||||||
|
Personal Care |
(4.5) |
5 |
1 |
1 |
(11) | ||||||||
|
Consumer Tissue |
(8.4) |
2 |
(1) |
— |
(9) | ||||||||
|
K-C Professional |
(3.5) |
3 |
— |
3 |
(9) | ||||||||
|
TOTAL CONSOLIDATED |
(5.7) |
4 |
— |
— |
(10) | ||||||||
|
(a) Mix/Other includes rounding. |
|||||||||||||
|
Unaudited |
|||||||||||||
|
OUTLOOK FOR 2015 | ||||||||||
|
| ||||||||||
|
ESTIMATED FULL YEAR 2015 DILUTED EARNINGS PER SHARE |
||||||||||
|
Adjusted earnings per share |
$ |
5.70 |
- |
$ |
5.80 |
|||||
|
Adjustments for: |
||||||||||
|
Charges for pension settlements |
(2.28) |
- |
(2.27) |
|||||||
|
Charges related to the 2014 Organization Restructuring |
(0.14) |
- |
(0.08) |
|||||||
|
Charge for Venezuelan balance sheet remeasurement |
(0.12) |
- |
(0.12) |
|||||||
|
Charges related to Turkey Restructuring |
(0.07) |
- |
(0.07) |
|||||||
|
Per share basis - diluted net income attributable to |
$ |
3.09 |
- |
$ |
3.26 |
|||||
|
ESTIMATED FULL YEAR 2015 EFFECTIVE TAX RATE |
||||||||||
|
Adjusted effective tax rate |
31.5 |
% |
- |
33.5 |
% | |||||
|
Adjustments for: |
||||||||||
|
Charges for pension settlements |
(5.2) |
- |
(5.1) |
|||||||
|
Charges related to the 2014 Organization Restructuring |
— |
- |
— |
|||||||
|
Charge for Venezuelan balance sheet remeasurement |
0.5 |
- |
0.5 |
|||||||
|
Charges related to Turkey Restructuring |
0.3 |
- |
0.3 |
|||||||
|
Effective tax rate |
27.1 |
% |
- |
29.2 |
% | |||||
[KMB-F]
Logo - http://photos.prnewswire.com/prnh/20110928/DA76879LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/kimberly-clark-announces-third-quarter-2015-results-300163462.html
SOURCE
News Provided by Acquire Media